Scotland will host the 16th Conference of Youth (COY16), the UN’s official youth event for COP26.
The Conference of Youth is an essential part of the COP calendar, helping to prepare young people for their participation in COP. It gives young people a voice in the climate negotiations, while providing delegates from over 140 countries the chance to meet, share experiences and build skills.
The conference will result in the Statement of Youth, which is presented on behalf of young people at every COP, setting out their hopes and expectations for the climate negotiations.
Five young people from Scotland will be selected to represent the country as delegates and contribute to the Statement.
This event, which runs from 28-31 October in Glasgow, will be funded by the Scottish Government and delivered by YOUNGO – the youth constituency of the United Nations Framework Convention on Climate Change (UNFCCC).
The First Minister said:“Young people have been among the strongest voices calling for urgent global action to address climate change. They have been an inspiration and I am proud that we are playing a role in giving them a platform at the heart of COP26 in Glasgow.
“The Conference of Youth will represent young people from 140 countries around the world, including here in Scotland. It is designed by young people, for young people, so they can set out their asks of world leaders ahead of the climate negotiations.
“Through this support we are ensuring that Scotland will play its part in securing an ambitious and deliverable global deal at COP26.
“I look forward to welcoming COY16 to Glasgow and engaging with them on our shared endeavour to tackle the climate crisis, with young people at the heart of our commitment to a just transition.”
Heeta Lakhani, YOUNGO Focal Point (Global South) and Marie-Claire Graf YOUNGO Focal Point (Global North) said:“The support of the Scottish Government is proof of legitimate youth inclusion and participatory governance in the lead up to the 26th UN Climate Conference.
“The official UN Climate Change Youth Constituency, YOUNGO, and the young climate advocates globally welcome this partnership not only to deliver COY16 and our presence in COP, but also as a sign that we are heard and involved.
“The commitment and backing of the Scottish Government will surely be part of the climate movement’s history. In these challenging times, it is important that we work on shared goals together. Let’s unify for change!”
Move follows unanimous advice to ministers from the four UK Chief Medical Officers
Parental consent will be sought prior to vaccination
People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine, following advice from the four UK Chief Medical Officers (CMOs), the Health and Social Care Secretary has announced. The Scottish Government is expected to make an announcement later today.
In line with the recommendation of the independent Joint Committee on Vaccination and Immunisation (JCVI), the government sought the views of the four UK CMOs on the wider issues that are relevant to the health of children.
The UK Government has accepted the advice of the four UK CMOs and the NHS is preparing to deliver a schools-based vaccination programme, which is the successful model used for vaccinations including for HPV and Diphtheria, Tetanus and Polio (DTP), supported by GPs and community pharmacies. Invitations for vaccination will begin next week.
Parental, guardian or carer consent will be sought by vaccination healthcare staff prior to vaccination in line with existing school vaccination programmes.
Healthy school-aged children aged 12 to 15 will primarily receive their COVID-19 vaccination in their school with alternative provision for those who are home schooled, in secure services or specialist mental health settings.
Health and Social Care Secretary, Sajid Javid said: “I have accepted the recommendation from the Chief Medical Officers to expand vaccination to those aged 12 to 15 – protecting young people from catching COVID-19, reducing transmission in schools and keeping pupils in the classroom.
“I am very grateful for the expert advice I have received from the Joint Committee on Vaccination and Immunisation and UK Chief Medical Officers.
“Our outstanding NHS stands ready to move forward with rolling out the vaccine to this group with the same sense of urgency we’ve had at every point in our vaccination programme.”
THE CHIEF MEDICAL OFFICERS’ LETTER READS:
To: Sajid Javid MP, Secretary of State for Health and Social Care, HM Government Eluned Morgan AS/MS, Minister for Health and Social Services, Welsh Government Humza Yousaf MSP, Cabinet Secretary for Health and Social Care, Scottish Government Robin Swann MLA, Minister of Health Northern Ireland Executive
13 September 2021
Dear Secretary of State, Cabinet Secretary and ministers,
Universal vaccination of children and young people aged 12 to 15 years against COVID-19
Background
The Joint Committee on Vaccination and Immunisation (JCVI) in their advice to you on 2 September 2021 on this subject said: ‘Overall, the committee is of the opinion that the benefits from vaccination are marginally greater than the potential known harms… but acknowledges that there is considerable uncertainty regarding the magnitude of the potential harms.
The margin of benefit, based primarily on a health perspective, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12 to 15-year-old children at this time…. JCVI is constituted with expertise to allow consideration of the health benefits and risks of vaccination and it is not within its remit to incorporate in-depth considerations on wider societal impacts, including educational benefits. The government may wish to seek further views on the wider societal and educational impacts from the Chief Medical Officers of the 4 nations, with representation from JCVI in these subsequent discussions.‘
You accepted this recommendation from JCVI, and wrote to us on 2 September 2021 stating “We agree with the approach suggested by JCVI, and so we are writing to request that you take forward work (drawing on experts as you see fit) to consider the matter from a broader perspective, as suggested by the JCVI.”
In doing so we have been fortunate to have been informed by the independent expertise of leaders of the clinical and public health profession from across the UK. This has included Presidents and Chairs or their representative of:
Royal College of Paediatrics and Child Health
Royal College of General Practice
Royal College of Psychiatry
Faculty of Public Health
Academy of Medical Royal Colleges representing all the other Royal Colleges and Faculties
Association of Directors of Public Health
Regional Directors of Public Health
national public health specialists
experts in data and modelling
We are very grateful to them for taking considerable time and effort to consult their own colleagues in all 4 nations at short notice to get a comprehensive view of the balance of informed medical opinion and experience across the UK.
The UK’s independent regulator of medicines and vaccines the Medicines and Healthcare products Regulatory Agency (MHRA) is in law the appropriate body to determine whether, based on risk-benefit grounds, a vaccine is safe and effective to use and so grant a licence. They have done so for children and young people aged over 12 years for two vaccines against COVID-19, those manufactured by Pfizer and Moderna. Their assessment is that benefits exceed risks on an individual basis. We take their independent opinion as read. The MHRA position on mRNA vaccines is similar to the relevant regulatory approvals granted in the same age groups in multiple other jurisdictions including but not limited to the USA, the European Union, and Canada.
The independent JCVI is the proper body to give advice on how to deploy a vaccine which has a prior favourable risk-benefit decision and authorisation from MHRA including whether it has a sufficiently large benefit to be worth deploying on a larger, population scale. Like MHRA they consider the benefits of vaccination in this age group exceed the risks (i.e. it is better to be vaccinated than not vaccinated in this age group).
They balanced the risk of COVID-19 against the risks of vaccination, including myocarditis. When forming its advice, the JCVI considered vaccine use according to clinical risk groups, thus identifying different groups according to their potential to benefit from vaccination.
For 12 to 15 year olds who do not have underlying health conditions that place them at higher risk from severe COVID-19, the JCVI considered that the size of both the risk and the benefit are at an individual level very small, and the overall advantage for vaccination, whilst present, is therefore not sufficiently large to recommend universal vaccination on their usual criteria.
They deemed the extent to which vaccination might mitigate the impacts of COVID-19 on education was beyond the usual remit of the JCVI. They recognised however that given the substantial scale of the impact of COVID-19 on all children and young people, which goes beyond normal clinical benefit and risk, wider issues could, exceptionally, be relevant hence their suggestion to consult UK CMOs.
The JCVI have already recommended that children and young people aged 12 to 17 with specific underlying health conditions, and children and young people who are aged 12 years and over who are household contacts of persons who are immunocompromised are offered two doses of a vaccine, normally Pfizer BioNTech BNT162b2. They have recommended all young people 16 to 17 are offered an initial first dose of vaccine.
The UK has benefited from having data from the USA, Canada and Israel, which have already offered vaccines universally to children and young people aged 12 to 15.
The UK CMOs start from the position that the MHRA and JCVI set out on individual benefit-risk calculations for this age group, and have not revisited this. We accept that at an individual level benefit exceeds risk but this advantage is small, and we have taken the JCVI figures as the UK current position on this question.
The Chair of the JCVI Prof. Lim has been a member of our group to ensure that there is no duplication of effort or conflict between the views of UK CMOs and the JCVI. We have been fortunate to have been joined also by the lead Deputy Chief Medical Officers for vaccines Prof. Van Tam (England), Prof. Steedman (Scotland) and Dr. Chada (Northern Ireland) and the DHSC Chief Scientific Adviser, Prof. Chappell. The final advice is that of the Chief Medical Officers, but informed by independent senior clinical and public health input from across the UK.
UK CMOs have decided in their ToR that we will only consider benefits and disbenefits to those aged 12 to 15 from vaccinating this age group, including indirect benefits. Whilst there may be benefits to other age groups, these have not been considered in our advice below.
Issues of vaccine supply were not factors considered in decision making.
The UK CMOs are aware of the extensive range of non-clinical views but this UK CMOs advice is purely clinical and public health derived and has not taken issues outside their clinical and public health remit into account. There is a subsequent political process where wider societal issues may be considered by ministers in deciding how they respond to this advice.
Advice
All drugs, vaccines and surgical procedures have both risks and benefits. If the risks exceed benefits the drug, vaccine or procedure should not be advised, and a drug or vaccine will not be authorised by MHRA. If benefits exceed risks then medical practitioners may advise the drug or vaccine, but the strength of their advice will depend on the degree of benefit over risk.
At an individual level, the view of the MHRA, the JCVI and international regulators is that there is an advantage to someone aged 12 to 15 of being vaccinated over being unvaccinated. The COVID-19 Delta variant is highly infectious and very common, so the great majority of the unvaccinated will get COVID-19. In those aged 12 to 15, COVID-19 rarely, but occasionally, leads to serious illness, hospitalisation and even less commonly death. The risks of vaccination (mainly myocarditis) are also very rare. The absolute advantage to being vaccinated in this age group is therefore small (‘marginal’) in the view of the JCVI. On its own the view of the JCVI is that this advantage, whilst present, is insufficient to justify a universal offer in this age group. Accepting this advice, UK CMOs looked at wider public health benefits and risks of universal vaccination in this age group to determine if this shifts the risk-benefit either way.
Of these, the most important in this age group was impact on education. UK CMOs also considered impact on mental health and operational issues such as any possible negative impact on other vaccine programmes, noting that influenza vaccination and other immunisations of children and young people are well-established, important, and that the annual flu vaccine deployment programme commences imminently.
The UK CMOs, in common with the clinical and wider public health community, consider education one of the most important drivers of improved public health and mental health, and have laid this out in their advice to parents and teachers in a previous joint statement. Evidence from clinical and public health colleagues, general practice, child health and mental health consistently makes clear the massive impact that absent, or disrupted, face-to-face education has had on the welfare and mental health of many children and young people. This is despite remarkable efforts by parents and teachers to maintain education in the face of disruption.
The negative impact has been especially great in areas of relative deprivation which have been particularly badly affected by COVID-19. The effects of missed or disrupted education are even more apparent and enduring in these areas. The effects of disrupted education, or uncertainty, on mental health are well recognised. There can be lifelong effects on health if extended disruption to education leads to reduced life chances.
Whilst full closures of schools due to lockdowns is much less likely to be necessary in the next stages of the COVID-19 epidemic, UK CMOs expect the epidemic to continue to be prolonged and unpredictable. Local surges of infection, including in schools, should be anticipated for some time. Where they occur, they are likely to be disruptive.
Every effort should be taken to minimise school disruption in policy decisions and local actions. Vaccination, if deployed, should only be seen as an adjunct to other actions to maintain children and young people in secondary school and minimise further education disruption and therefore medium and longer term public health harm.
On balance however, UK CMOs judge that it is likely vaccination will help reduce transmission of COVID-19 in schools which are attended by children and young people aged 12 to 15 years. COVID-19 is a disease which can be very effectively transmitted by mass spreading events, especially with Delta variant. Having a significant proportion of pupils vaccinated is likely to reduce the probability of such events which are likely to cause local outbreaks in, or associated with, schools. They will also reduce the chance an individual child gets COVID-19. This means vaccination is likely to reduce (but not eliminate) education disruption.
Set against this there are operational risks that COVID-19 vaccination could interfere with other, important, vaccination programmes in schools including flu vaccines.
Overall however the view of the UK CMOs is that the additional likely benefits of reducing educational disruption, and the consequent reduction in public health harm from educational disruption, on balance provide sufficient extra advantage in addition to the marginal advantage at an individual level identified by the JCVI to recommend in favour of vaccinating this group.
They therefore recommend on public health grounds that ministers extend the offer of universal vaccination with a first dose of Pfizer-BioNTech COVID-19 vaccine to all children and young people aged 12 to 15 not already covered by existing JCVI advice.
If ministers accept this advice, UK CMOs would want the JCVI to give a view on whether, and what, second doses to give to children and young people aged 12 to 15 once more data on second doses in this age group has accrued internationally. This will not be before the spring term.
In recommending this to ministers, UK CMOs recognise that the overwhelming benefits of vaccination for adults, where risk-benefit is very strongly in favour of vaccination for almost all groups, are not as clear-cut for children and young people aged 12 to 15. Children, young people and their parents will need to understand potential benefits, potential side effects and the balance between them.
If ministers accept this advice, issues of consent need to take this much more balanced risk-benefit into account. UK CMOs recommend that the Royal Colleges and other professional groups are consulted in how best to present the risk-benefit decisions in a way that is accessible to children and young people as well as their parents. A child-centred approach to communication and deployment of the vaccine should be the primary objective.
If ministers accept this advice, it is essential that children and young people aged 12 to 15 and their parents are supported in their decisions, whatever decisions they take, and are not stigmatised either for accepting, or not accepting, the vaccination offer. Individual choice should be respected.
Chief Medical Officer for England Prof. Christopher Whitty
Chief Medical Officer for Northern Ireland Sir Michael McBride
Chief Medical Officer for Scotland Dr. Gregor Smith
Chief Medical Officer for Wales Dr. Frank Atherton
Over four in five adults across the UK have received both COVID-19 vaccine doses, with over half of all 16 and 17 year olds coming forward for their first jab.
However COVID numbers continue to rise across the UK. 28,856 new cases were reported yesterday, with 4241 of these in Scotland. The daily Scottish figure is likely to be considerably higher due to an IT problem.
Responding to the advice from the Chief Medical Officers regarding the vaccination of all 12-15 year olds, Bruce Adamson, the Children and Young People’s Commissioner Scotland, said: “We welcome the advice to offer the vaccine to children between the age of 12 and 15. It is important to give them that choice.
“Children and young people have a right to the best possible health, that’s not just about protection from the Covid virus itself, but also the impact on their mental health due to isolation and other factors. The pandemic has impacted their right to education, their right to play, their right to see wider family and friends which is so essential to their development. Their education has been disrupted with two long periods of school closures.
“It is important that children are supported to make informed decisions about their own health. Children of this age group have told me over the last few months that they are in favour of having the choice to be vaccinated. That is not to say that all of them had made a decision about whether they would get a vaccine, but they wanted the option to be available to them. Of course, there have been some children who are concerned about vaccination, or who told me about parental concerns. It is important that there is no stigma attached to the choices that children make about vaccination.
“It is essential that this advice is communicated directly to 12 to 15 year olds in a child-friendly way so they can understand why they are now being offered the vaccine, and can have any questions they might have answered in a way they can understand. Children have the right to access appropriate information on decisions affecting them.
“Parents and carers will play an important role in supporting the decision-making around whether a child chooses to get vaccinated so it is important that they have all of the necessary information to support that choice.”
Stocks of personal protective equipment (PPE) are to be donated to Africa to aid their response to the COVID-19 pandemic.
The PPE equipment, worth £11.2 million, will be distributed by Kids Operating Room (KidsOR), a Scottish-based global health charity.
This distribution will be supported by £250,000 from the Scottish Government, which will fund the transport of 25 shipping containers of material to Malawi, Rwanda and Zambia.
KidsOR raised a further £1 million to support the transport of the PPE from the Wood Foundation, Pula Limited, Postcode Trust and Delta Philanthropies.
The supplies include masks, goggles, and visors and the shipment, made available through the NHS Scotland Global Citizenship Programme, is due to arrive in partner countries in late September.
International Development Minister Jenny Gilruth said: “COVID-19 knows no borders. I am pleased that the Scottish Government has been able to support this assistance to Malawi, Rwanda and Zambia – particularly as they look to plan for an expected fourth wave of COVID-19 in the coming months.
“This contribution builds on our recent supply of oxygen concentrators and ventilators, and we hope it will go some way to easing the current stress on health services.
“As the global pandemic continues, we firmly believe this is precisely the moment that Governments across the world should be stepping up to help those most in need.
“This donation underlines that the Scottish Government remains fully committed to playing our part in tackling the shared global challenge that the pandemic represents. I would like to thank KidsOR for supporting us to make it possible to distribute this PPE equipment along with the recent supply of oxygen concentrators and ventilators.”
Chief Executive of NHS National Services Scotland (NSS) Mary Morgan said: “The battle to beat COVID is truly a global effort. We are pleased that PPE secured by NSS is being donated to help those who need it most in Africa.
“We will continue to work with partners to identify further opportunities to support countries and communities who need our help.”
Co-Founder of KidsOR Garreth Wood said: “I would like to thank our donors for stepping up to help support the distribution of so many millions of items of PPE that will prove vital for countries in Africa battling the ongoing COVID pandemic.”
Scotland’s Climate Week runs from Monday 13 September to Sunday 19 September
A week-long programme of events and initiatives launches across the country today to engage businesses, organisations and communities in Scotland’s response to the global climate emergency ahead of COP26.
Scotland’s Climate Week 2021 will turn the spotlight on the November summit by highlighting Scotland’s national and international actions on climate change while building awareness, generating conversations and encouraging commitment to further climate action.
Climate Week will include the launch of a series of Climate Festival events, part of a new engagement programme designed to empower local communities in the climate debate and ensure an inclusive approach which leaves no-one behind.
Businesses, organisations and individual groups are being encouraged to take to social media to make a pledge they will commit to during COP26 to tackle climate change.
Net Zero Secretary Michael Matheson said: “COP26 coming to Scotland is a unique opportunity to advance the society-wide transformation required for us to become a net zero nation.
“I am determined to make sure the conference reaches out far beyond the negotiations in Glasgow. It must reach every community and deliver a lasting legacy that accelerates our emissions reduction whilst making absolutely sure we do that in a way that’s fair and leaves no-one behind.
“Becoming a net zero nation will require a huge national effort with all of us embracing the significant changes and the chance to secure a better future for us all. It’s crucial that everyone takes this opportunity to get involved. Only by taking action together will we succeed in creating a fairer, greener and climate resilient society.
“In addition to being part of the events taking place up and down the country this week, businesses, organisations, community groups, and individuals can be part of the COP26 Call to Action by making a pledge on social media to commit to climate action for the two weeks of the summit and beyond.”
Scotland’s Climate Week runs from Monday 13 September to Sunday 19 September.
A new fund worth more than £1 million that will help libraries re-open is being launched by the Scottish Government.
The Public Libraries COVID Recovery Fund will allow libraries to re-connect with their communities as part of Scotland’s recovery from the pandemic.
The fund, which will be distributed through the Scottish Library and Information Council (SLIC), will support libraries in re-opening or extending their opening hours, as well as fund targeted plans for issues such as digital exclusion or mental health and wellbeing.
While priority will be given to applications which support deprived areas and communities, all library services across Scotland are invited to apply for the fund, which is a commitment made in the new Programme for Government.
Culture Minister Jenny Gilruth said: “We hope that through this new fund the power of libraries to inform, educate, entertain and inspire can be unlocked again as part of the recovery from the COVID pandemic.
“We are aware that while many have returned, Scotland’s library services are currently operating below their pre-pandemic levels.
“The reasons for these closures are varied, complex and sometimes challenging – however we want to see as many libraries re-open as possible, and this fund will help the public library sector bounce back from a challenging time.”
Scottish Library and Information Council chair Ian Ruthven said: “The effects of the COVID-19 pandemic have highlighted the vital role public libraries play in communities across Scotland.
“Libraries are at the centre of the collective endeavour to improve literacy, close the attainment gap, promote health, champion wellbeing, pioneer sustainability, reduce inequality, and close the digital divide.
“SLIC is pleased to be working with the Scottish Government to administer the Public Library Covid Relief Fund which will support the public library sector to extend access to these vital services, and prioritise wellbeing as communities continue to rebuild and recover.”
Health Secretary Humza Yousaf has announced a new £10 million Long COVID Support Fund to help health boards respond to the condition.
The announcement follows Mr Yousaf meeting with a range of healthcare professionals at Eastwood Health and Care Centre in East Renfrewshire and speaking with patient Pamela Bell who has been receiving support for long COVID since she contracted the virus almost a year ago.
The Long COVID Support Fund is designed to maximise and improve the co-ordination of a broad range of existing services across the health and social care system and Third Sector in response to the condition. It will be a flexible fund that will be tailored to local needs. It will strengthen the range of information and advice available, and ensure the right support is available within primary care, providing a response focused on each patient’s needs, with referrals to secondary care where necessary.
Mr Yousaf said:
“We know that long COVID can’t be handled with a one-size-fits-all approach. It can be complex and involve an array of diverse symptoms and combinations of those symptoms.
“The new Long COVID Support Fund will give our NHS Boards the flexibility to design and deliver the best care for those with long COVID, tailored to the specific needs of their populations.
“It’s been great to meet Pamela and hear how she has benefited from care and rehabilitation in a setting close to home. Long COVID patients are being supported by the full range of NHS services – primary care teams and community-based rehabilitation services with referrals to secondary care where necessary – and I want to thank our dedicated staff for their hard work.”
Mrs Bell, 62, from Glasgow, met with the Health Secretary to discuss her experience since testing positive for COVID last September. She has a mild chest condition – bronchiectasis – which meant she had to shield at the start of the pandemic. After contracting the virus she was admitted to hospital where she ended up in intensive care and intubated for almost three months.
By the time she was transferred to a respiratory ward on Hogmanay, she could not move and ultimately went to a Physical Disability Rehabilitation Unit for intensive physiotherapy and Occupational Therapy.
She also received intervention and oxygen therapy in a respiratory ward, and returned home with long-term oxygen at the beginning of June, where she receives ongoing care from a Community Rehabilitation Team to support her to regain her independence, function and mobility. Mrs Bell, who previously worked in a children’s nursery, has had to retire due to ill health.
Mrs Bell, a mother-of-two who is due to become a grandmother next Spring, said:
“Recently I was able to walk for two minutes and 40 seconds – which is a huge achievement for me.
“Before COVID, I was a senior child development officer, which involved outdoor play. I’d be in the playground or taking the children on forest walks, doing at least 15,000 steps a day. I’d help out in my community. I was there for everybody.
“This last year has been a challenge, when I’ve had to let other people take care of me. But I’m blown away by everything I’ve been given by the NHS. They are just amazing. Some of them visit me weekly, some are at the end of the phone, they deliver my oxygen and really look after me.”
Details of the new Long COVID Support Fund will be shared with NHS Boards in due course.
Scotland’s largest ever vaccination programme will complete second doses for all over 18s who have attended their scheduled appointments by close of play on Sunday 12 September.
Some of those eligible have rearranged their appointment for health or work reasons and will get their second dose shortly. Vaccination Clinics will remain open and anyone who has not yet received their vaccination, for whatever reason is reminded that it is never too late to get vaccinated and is urged to go to a local drop-in clinic or go to NHS Inform to book a convenient appointment.
The second dose of the vaccine offers greater and longer lasting protection and can be given from eight weeks after the first, either at a drop-in clinic or by requesting an appointment through the NHS Inform website.
Evidence shows that after two doses the vaccines are more than 90% effective against hospital admissions from the effects of the virus.
Students from the UK and abroad are included in the national programme and are encouraged to come forward for vaccination regardless of whether they require their first, second or both doses.
Health Secretary Humza Yousaf said: “Today is a significant day because every single adult in Scotland has now been given the opportunity to be fully vaccinated against COVID-19.
“I want to pass on my thanks to all those who have helped make this possible – from the scientists who developed the vaccine, to the hard-working staff delivering the programme on the ground. I also want to thank everyone who has taken up their offer of a vaccine, and rolled up their sleeves to help tackle coronavirus.
“To all those who haven’t yet had their second doses, please don’t leave the job half done. Even if the time since the first dose is more than eight weeks, people can still be vaccinated and I encourage them to come forward.
“We have made getting a vaccination easier than ever – head to one of the drop-in clinics being offered across the country or, if you prefer, book an appointment online at NHS Inform. Please check your NHS board’s social media posts for the latest information on where you can attend.
“Students heading to university or college from anywhere in the UK or abroad are reminded they too are urged to take up this offer if it’s relevant to them – indeed, in addition to drop-in clinics around the country, mobile vaccination units are visiting several further education campuses.
“Recent increases in case numbers mean it remains crucial everyone who is offered a vaccination takes up the invitation.”
Health Secretary Humza Yousaf has confirmed that the outline business case for the new Edinburgh Eye Pavilion has been approved by the Scottish Government.NHS Lothian has now been invited to submit a full business case.
This will be part of a £10 billion investment in the NHS estate over the next 10 years, bringing about the renewal and replacement of health facilities across Scotland.
Mr Yousaf said: “I am delighted that we are a step closer to delivering improved specialised eye services for the city of Edinburgh and the wider region.
“The Scottish Government is committed to working closely with NHS Lothian to meet the demand for eye care, with improvements for patients and a more modernised service.”
Earlier this year, the Scottish Government asked NHS Lothian to carry out a review of eye care services, including redesigning pathways to enable patients to access care closer to home.
With just over 50 days to go until COP26 comes to Glasgow, details of Scotland’s COP26 community engagement programme have been announced.
The programme of climate change activity will engage communities in the journey to net zero and empower them to take action.
It will include activity targeted at communities that have not previously engaged in climate action, helping to make Scotland’s COP26 engagement inclusive.
The programme also includes activity for young people, including schools and youth groups such as the guiding and scouting movements, to help ensure children and young people from all backgrounds can participate.
Scotland’s climate festivals will support local communities to plan and deliver their own festivals and events across the country.
Keep Scotland Beautiful and the Glasgow Science Centre will lead on delivery, backed with almost £500,000 of Scottish Government funding.
Cabinet Secretary for Net Zero, Energy and Transport Michael Matheson said:“COP26 coming to Scotland is a unique opportunity to advance the society-wide transformation demanded by the climate crisis.
“That’s why we are determined to make sure the event reaches out far beyond the negotiations in Glasgow, into every community in the country.
“Scotland has made great progress in delivering its world-leading climate targets and is already over half way to net zero. To end our contribution to climate change within a generation, we will all need to play role. Our communities and young people will be at the heart of that action. This programme will help empower everyone to take action to tackle climate change – especially those that might have not previously engaged.”
Barry Fisher, CEO of Keep Scotland Beautiful, said:“We’re delighted to be working with the Scottish Government and partners to ensure everyone is empowered to navigate the climate emergency challenges ahead.
“COP26 happening in Scotland must be a catalyst to broaden and intensify climate conversations nationally and locally. We want to bring the issues discussed at the summit to the heart of communities by unlocking opportunities for those currently not engaged in climate change action to make their voices heard, and to provide much needed energy and support.”
Dr Stephen Breslin, CEO Glasgow Science Centre, said:“Our World, Our Impact aims to make climate science relevant to day-to-day life, inviting everyone to explore how we can all play a part in the discussion as Glasgow prepares to host COP26.
“We are also delighted to be working together with our colleagues from Scotland’s other science centres to look at how we can engage underserved audiences in the climate conversation across Scotland.”
Scottish Ambulance Service Mobile Testing Unit (MTU) teams have delivered more than one million tests in just over a year.
The MTUs have been one of biggest projects ever carried out at the Scottish Ambulance Service (SAS).
There are now 39 MTU teams across the country and more than 1100 people employed by the Scottish Ambulance Service, providing a vital service to Scotland.
The MTUS can be dispatched quickly across the country so people in urban, rural and remote areas have easy access to a coronavirus test. The location of the units, planned by National Services Scotland and local resilience partnerships, changes regularly to reflect demand.
John Alexander, General Manager for the Mobile Testing Units (MTUs), said: “The introduction of MTUs has played an important role in the country’s fight against Covid-19, helping to control the spread of the virus.
“All of our MTU staff have done a fantastic job in providing tests to the people of Scotland over the past year and I’m extremely proud they’ve delivered more than one million tests since last September.”
Cabinet Secretary for Health and Social Care Humza Yousaf said: “Reaching one million tests is a major milestone and recognition of the hard work and dedication of Scottish Ambulance Service. My heartfelt thanks go to SAS staff for what they do every single day to care for, and support people across Scotland.
“Our COVID-19 Mobile Testing Units have played a crucial role in bringing testing resources to the communities who need it most. By identifying and isolating cases, we are breaking chains of transmission within those communities and giving us a better chance of stopping the virus from spreading.”
